Prescriptions for cannabis-based medicines double in a year, CQC report says

Prescriptions for unlicensed cannabis-based products for medicinal use (CBPMs) more than doubled in England between 2021/2022 and 2022/2023, Care Quality Commission data have revealed. A report from the CQC, the independent regulator of health and adult social care in England — ‘The safer management of controlled drugs: annual update 2023‘ — said that 177,566 items … Continue reading Prescriptions for cannabis-based medicines double in a year, CQC report says